Average Co-Inventor Count = 5.81
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sanofi-aventis (3 from 389 patents)
2. Sanofi (2 from 1,454 patents)
3. Mitsubishi Pharma Corporation (2 from 73 patents)
4. Perha Pharmaceuticals (1 from 2 patents)
5. Mitsubishi Tanabe Pharma Corporation (257 patents)
6. Step Pharma S.a.s. (5 patents)
6 patents:
1. 12398129 - Imidazolone derivatives as inhibitors of protein kinases in particular DYRK1A, CLK1 and/or CLK4
2. 8846676 - 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
3. 8354405 - 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
4. 7507743 - Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivatives
5. 7476756 - Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics
6. 7294632 - Substituted 8'-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives